Deutsche Bank says the firm’s channel checks suggest “broad and growing interest” in cheaper remanufactured instruments at robotics programs. Intuitive’s instruments and accessories franchise, which represents 60% of its total sales, are at risk by remanufactured da Vinci instruments over the next few years, the analyst tells investors in a research note. Deutsche expects “significant and growing engagement” with remanufacturers by larger hospital systems. It keeps a Sell rating on Intuitive Surgical (ISRG) shares with a $440 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical weakness attributed to Surgical Science comments
- Intuitive Surgical selloff brings attractive opportunity, says Leerink
- Intuitive Surgical’s New Study: A Closer Look at the Ion Endoluminal System
- Intuitive Surgical’s Strong Performance and Growth Potential Reinforce Buy Rating
- Intuitive Surgical’s Earnings Call: Growth Amid Challenges